Mackenzie Financial
BVS icon

Mackenzie Financial’s Bioventus BVS Stock Holding History

Mackenzie Financial’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-41,090
Closed -$376K – 1718
2025
Q1 		$376K Buy
41,090
+8,824
+27% +$88.1K ﹤0.01% 1299
2024
Q4 		$339K Buy
+32,266
New +$382K ﹤0.01% 1336
2024
Q3 		– Sell
-13,335
Closed -$76.7K – 1594
2024
Q2 		$76.7K Buy
+13,335
New +$73.2K ﹤0.01% 1458

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Mackenzie Financial's BVS Position: Q2 2025 in Review

Mackenzie Financial sold out of Bioventus (BVS) in Q2 2025, closing a stake of 41,090 shares — an estimated $376K sold.

Mackenzie Financial first reported a position in BVS in Q2 2024 and held it in 3 quarters. The position peaked at $376K in Q1 2025. 134 funds tracked by Wall St. Rank hold BVS as of Q2 2025.

  • Mackenzie Financial reported no remaining Bioventus position as of Q2 2025 after selling out during the quarter.
  • Mackenzie Financial sold 41,090 Bioventus shares in Q2 2025, an estimated $376K.
  • Mackenzie Financial first reported a position in Bioventus in Q2 2024 and held it in 3 quarters.
  • Mackenzie Financial's Bioventus position peaked at $376K in Q1 2025.
  • 134 funds tracked by Wall St. Rank held Bioventus as of Q2 2025.

Based on Mackenzie Financial's 13F filing for Q2 2025, filed 13 Aug 2025.